Free Trial

Tempest Therapeutics (TPST) Short Interest Ratio & Short Volume

$3.20
-0.04 (-1.23%)
(As of 05/28/2024 ET)

Tempest Therapeutics Short Interest Data

Current Short Interest
1,680,000 shares
Previous Short Interest
1,580,000 shares
Change Vs. Previous Month
+6.33%
Dollar Volume Sold Short
$5.68 million
Short Interest Ratio
2.0 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
22,220,000 shares
Float Size
17,480,000 shares
Short Percent of Float
9.61%
Today's Trading Volume
189,581 shares
Average Trading Volume
805,218 shares
Today's Volume Vs. Average
24%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Tempest Therapeutics ?

Sign up to receive the latest short interest report for Tempest Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TPST Short Interest Over Time

TPST Days to Cover Over Time

TPST Percentage of Float Shorted Over Time

Tempest Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20241,680,000 shares $5.68 million +6.3%9.6%2 $3.38
4/30/20241,580,000 shares $5.48 million +39.8%9.4%1.8 $3.47
4/15/20241,130,000 shares $3.77 million +16.5%6.7%1.2 $3.34
3/31/2024969,700 shares $3.79 million +26.5%6.1%0.9 $3.91
3/15/2024766,800 shares $2.79 million +7.0%4.2%1 $3.64
2/29/2024716,500 shares $2.66 million -17.7%4.5%0.8 $3.71
2/15/2024870,400 shares $3.46 million +14.5%5.4%0.8 $3.98
1/31/2024759,900 shares $2.88 million +37.1%5.6%0.4 $3.79
1/15/2024554,300 shares $2.34 million +19.6%4.1%0.2 $4.23
12/31/2023463,400 shares $2.04 million -44.8%3.4%0 $4.40
12/15/2023838,900 shares $3.45 million +31.4%6.2%0.1 $4.11
11/30/2023638,600 shares $2.24 million -54.1%5.8%0.1 $3.52
11/15/20231,390,000 shares $4.59 million -0.7%12.5%0.1 $3.30
10/31/20231,400,000 shares $5.74 million -36.1%18.2%0.1 $4.10
10/15/20232,190,000 shares $7.97 million +7,200.0%28.5%0.3 $3.64
9/30/202330,000 shares $9,141.00 -64.7%0.4%0.1 $0.30
9/15/202385,000 shares $41,378.00 +161.5%1.1%0.6 $0.49
8/31/202332,500 shares $17,485.00 +128.9%0.5%0.3 $0.54
8/15/202314,200 shares $9,315.20 -58.6%0.2%0.1 $0.66
7/31/202334,300 shares $33,271.00 -15.9%0.6%0.4 $0.97
7/15/202340,800 shares $47,532.00 +58.1%0.7%0.2 $1.17
6/30/202325,800 shares $32,766.00 -39.3%0.5%0.1 $1.27
6/15/202342,500 shares $60,350.00 +6.5%0.7%0.2 $1.42
5/31/202339,900 shares $61,047.00 -48.8%0.8%0.2 $1.53
5/15/202377,900 shares $169,822.00 +144.2%1.5%0.3 $2.18
4/30/202331,900 shares $67,628.00 -3.3%0.8%0.1 $2.12
4/15/202333,000 shares $97,350.00 -29.9%0.8%1.1 $2.95
3/31/202347,100 shares $109,272.00 +262.3%1.1%1.8 $2.32
3/15/202313,000 shares $16,380.00 -21.2%0.3%0.8 $1.26
2/28/202316,500 shares $29,040.00 +17.9%0.4%1 $1.76
2/15/202314,000 shares $24,360.00 -21.4%0.3%0.9 $1.74
1/31/202317,800 shares $35,422.00 -41.3%0.3%1.1 $1.99
1/15/202330,300 shares $52,419.00 +31.7%0.7%1.9 $1.73
12/30/202223,000 shares $26,450.00 +33.7%0.5%1.6 $1.15
12/15/202217,200 shares $24,768.00 -12.2%0.4%1.9 $1.44
11/30/202219,600 shares $31,322.76 +22.5%0.4%1.2 $1.60
11/15/202216,000 shares $26,400.00 -20.8%0.4%0.8 $1.65
10/31/202220,200 shares $37,370.00 +3.1%0.4%0.8 $1.85
10/15/202219,600 shares $31,164.00 -9.7%0.4%0.7 $1.59
9/30/202221,700 shares $37,758.00 -10.0%0.5%0.8 $1.74
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
9/15/202224,100 shares $56,876.00 +28.2%0.5%0.8 $2.36
8/31/202218,800 shares $40,608.00 -68.4%0.4%0.7 $2.16
8/15/202259,400 shares $147,906.00 -39.6%1.3%1.3 $2.49
7/31/202298,400 shares $199,752.00 -20.6%2.2%1.6 $2.03
7/15/2022123,900 shares $314,706.00 -7.3%2.8%0.4 $2.54
6/30/2022133,600 shares $287,240.00 -23.6%3.0%0.4 $2.15
6/15/2022174,900 shares $372,537.00 -24.5%3.9%0.5 $2.13
5/31/2022231,700 shares $667,296.00 +23.2%12.4%0.7 $2.88
5/15/2022188,000 shares $541,440.00 -59.0%14.5%0.6 $2.88
4/30/2022458,800 shares $1.66 million +1,835.9%14.5%1.6 $3.61
4/15/202223,700 shares $80,817.00 +22.8%0.8%0.7 $3.41
3/31/202219,300 shares $65,234.00 +1.1%0.6%0.6 $3.38
3/15/202219,100 shares $44,121.00 -19.4%0.6%0.6 $2.31
2/28/202223,700 shares $77,262.00 +2.2%0.8%0.7 $3.26
2/15/202223,200 shares $80,504.00 -12.5%0.7%0.8 $3.47
1/31/202226,500 shares $105,205.00 -18.0%0.5%0.9 $3.97
1/15/202232,300 shares $132,753.00 -0.6%0.6%1.1 $4.11
12/31/202132,500 shares $171,600.00 +8.7%0.6%1.2 $5.28
12/15/202129,900 shares $210,795.00 -19.2%0.6%1.7 $7.05
11/30/202137,000 shares $366,300.00 -19.9%0.7%1.6 $9.90
11/15/202146,200 shares $509,586.00 -16.3%0.9%1.5 $11.03
10/29/202155,200 shares $646,944.00 -2.8%1.1%1.1 $11.72
10/15/202156,800 shares $833,824.00 -30.7%1.1%0.5 $14.68
9/30/202182,000 shares $1.19 million +0.7%1.7%0.2 $14.47
9/15/202181,400 shares $1.26 million +93.4%1.6%0.1 $15.44
8/31/202142,100 shares $606,661.00 -56.1%0.9%0.1 $14.41
8/13/202195,900 shares $1.28 million No ChangeN/A0.1 $13.30
6/15/20212,420,000 shares $3.48 million +22.2%15.1%1.1 $1.44
5/28/20211,980,000 shares $2.36 million +28.6%12.3%1.2 $1.19
5/14/20211,540,000 shares $1.48 million +31.6%N/A1.1 $0.96
4/30/20211,170,000 shares $1.33 million +3.5%N/A1 $1.14
4/15/20211,130,000 shares $1.22 million +123.1%N/A1.3 $1.08
3/31/2021506,400 shares $648,192.00 +62.5%N/A0.6 $1.28
3/15/2021311,600 shares $663,708.00 -0.5%N/A0.5 $2.13
2/26/2021313,000 shares $694,860.00 -28.3%N/A0.5 $2.22
2/12/2021436,700 shares $1.14 million -33.0%N/A0.7 $2.62
1/29/2021651,400 shares $1.21 million -7.3%N/A1.1 $1.86
1/15/2021702,700 shares $1.28 million +55.6%N/A1.4 $1.82
12/31/2020451,600 shares $961,908.00 +11.9%N/A1 $2.13
12/15/2020403,500 shares $786,825.00 -26.6%N/A1 $1.95
11/30/2020549,700 shares $1.03 million -13.5%N/A1.6 $1.88
11/15/2020635,800 shares $979,132.00 +36.2%N/A1.8 $1.54
10/30/2020466,800 shares $690,864.00 -51.2%N/A1.3 $1.48
10/15/2020955,500 shares $1.61 million +39.2%N/A2.3 $1.69
9/30/2020686,400 shares $1.12 million +25.9%N/A1.2 $1.63
9/15/2020545,100 shares $877,611.00 +38.5%N/A0.9 $1.61
8/31/2020393,500 shares $712,235.00 -22.8%N/A0.3 $1.81
8/14/2020509,700 shares $942,945.00 -39.1%N/A0.4 $1.85
7/31/2020836,500 shares $1.45 million -6.5%N/A0.6 $1.73
7/15/2020894,800 shares $1.52 million -10.5%N/A0.6 $1.70
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
6/30/20201,000,000 shares $1.76 million +32.4%7.5%0.6 $1.76
6/15/2020755,100 shares $1.53 million +34.6%5.7%0.5 $2.02
5/29/2020561,100 shares $1.49 million +5.9%4.2%0.5 $2.66
5/15/2020529,800 shares $863,574.00 +19.9%4.0%0.6 $1.63
4/30/2020442,000 shares $738,140.00 +43.6%3.4%0.6 $1.67
4/15/2020307,900 shares $489,561.00 +6.3%2.8%0.6 $1.59
3/31/2020289,700 shares $434,550.00 +8.8%2.8%1 $1.50
3/13/2020266,300 shares $378,146.00 +67.5%2.7%1.2 $1.42
2/28/2020159,000 shares $1.03 million -16.9%1.6%1.4 $6.45
2/14/2020191,400 shares $1.29 million +31.4%1.9%2.1 $6.72
1/31/2020145,700 shares $1.26 million +5.7%1.4%2.1 $8.68
1/15/2020137,800 shares $920,504.00 +9.7%1.3%2.2 $6.68
12/31/2019125,600 shares $1.04 million +20.0%1.2%2.3 $8.28
8/15/2019264,300 shares $1.85 million +7.1%4.8%4.7 $6.99

TPST Short Interest - Frequently Asked Questions

What is Tempest Therapeutics' current short interest?

Short interest is the volume of Tempest Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,680,000 shares of TPST short. 9.61% of Tempest Therapeutics' shares are currently sold short. Learn More on Tempest Therapeutics' current short interest.

What is a good short interest ratio for Tempest Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TPST shares currently have a short interest ratio of 2.0. Learn More on Tempest Therapeutics's short interest ratio.

What is a good short interest percentage for Tempest Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.61% of Tempest Therapeutics' floating shares are currently sold short.

Is Tempest Therapeutics' short interest increasing or decreasing?

Tempest Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,680,000 shares, an increase of 6.3% from the previous total of 1,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tempest Therapeutics' float size?

Tempest Therapeutics currently has issued a total of 22,220,000 shares. Some of Tempest Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tempest Therapeutics currently has a public float of 17,480,000 shares.

How does Tempest Therapeutics' short interest compare to its competitors?

9.61% of Tempest Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tempest Therapeutics: BioXcel Therapeutics, Inc. (4.34%), Marinus Pharmaceuticals, Inc. (8.90%), Eledon Pharmaceuticals, Inc. (0.77%), Checkpoint Therapeutics, Inc. (12.68%), Affimed (1.77%), Landos Biopharma, Inc. (0.05%), MediciNova, Inc. (0.34%), Aileron Therapeutics, Inc. (1.26%), Spero Therapeutics, Inc. (0.92%), Lantern Pharma Inc. (5.50%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Tempest Therapeutics stock?

Short selling TPST is an investing strategy that aims to generate trading profit from Tempest Therapeutics as its price is falling. TPST shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tempest Therapeutics?

A short squeeze for Tempest Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TPST, which in turn drives the price of the stock up even further.

How often is Tempest Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TPST, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TPST) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners